CMEF Successfully Ends | Canta's Independent Research and Development Strength, Opening a New Future for the Oxygen Production Industry

On April 14, 2024, the 89th China International Medical Device (Spring) Expo with the theme of "Innovative Technology, Smart Leading the Future" was successfully concluded at the National Convention and Exhibition Center (Shanghai).

Gathering cutting-edge technology to jointly create a new future for the medical industry

At this exhibition, nearly 5000 brand enterprises from over 30 countries and regions around the world made a concentrated appearance with tens of thousands of products, attracting over 200000 professional visitors from over 150 countries and regions to visit. Nearly a thousand industry experts, elites, and opinion leaders gathered in Shenzhen to bring a medical feast of intellectual fusion and collision of perspectives to the global health industry.

Canta exert precise force, showcasing the hard power of "China's intelligent manufacturing"

Driven by technological innovation, Canta Medical actively responds to complex and ever-changing industry challenges and challenges, focuses on core research and development capabilities, and creates two new series of products -- the new VPSA series oxygen generator and micro high-pressure hyperbaric chamber, aiming to provide comprehensive solutions for home oxygen therapy and provide a better oxygen therapy experience for millions of users.

Scientific research and innovation achievements shine and attract countless attention

At the exhibition, the new oxygen concentrator and micro high-pressure hyperbaric chamber of Canta VPSA, with its advanced technology and technological charm, won the favor of many participating customers. Everyone stopped to observe and experience, and after listening to the demonstration and explanation of the staff, they recognized the scientific research and innovation ability of Canta Medical and expressed strong anticipation for the launch of these two new products.

In recent years, driven by policy support and technological progress, the domestic oxygen production industry has achieved breakthrough development. As a high-tech enterprise that has been deeply involved in the oxygen production industry for 20 years, Canta Medical will continuously improve its independent research and development capabilities, continue to adhere to the concept of "technological innovation, dedicated manufacturing", and make all-round efforts to provide users with higher quality products and services, fully breaking through the domestic oxygen production industry market and leading the industry's high-quality development.